Feb 4, 2014 by Dave WilliamsonWhy Gilead Sciences, Inc. Won Big TodayGilead Sciences won big in the biotech space today. How should investors play this move?
Feb 4, 2014 by Dave WilliamsonWhy Furiex Pharmaceuticals Inc. Is an Instant DoubleFuriex pulls the classic biotech instant double. How should investors play this fast-moving stock?
Jan 31, 2014 by Dave WilliamsonWhy Vanda Pharmaceuticals Won Big TodayHow an FDA approval for this sleep/wake disorder drug made Vanda Pharmaceuticals today's big biotech winner.
Jan 31, 2014 by Dave WilliamsonWhy InterMune Inc. Lost Big TodayHere's why InterMune was hit hard today, through no fault of its own.
Jan 30, 2014 by Dave WilliamsonWhy Alexion Pharmaceuticals and Dicerna Pharmaceuticals Inc Won Big TodayTwo massive winners in biotech stocks today, including one staggeringly skyrocketing IPO.
Jan 28, 2014 by Dave WilliamsonInvestors Focus on Fortune-Making Immuno-Oncology RaceWho will win the high-stakes immuno-oncology race?
Jan 28, 2014 by Dave WilliamsonHow Gilead Sciences, Inc. Could Push Back on Sovaldi PricingThe price for Gilead's new hepatitis C cure seems exorbitant to some, and now pharmacy benefit managers are starting to push back along with the protestors. Here's why Gilead's pricing will still probably hold.
Jan 28, 2014 by Dave WilliamsonDecoding Pfizer Inc.'s Strong Earnings and Game-Changing PipelineHere's why Pfizer is absolutely a stock to watch in the months ahead.
Jan 28, 2014 by Dave WilliamsonWhy Cambrex Corporation SoaredHere's why Cambrex won big on the market today.
Jan 27, 2014 by Dave WilliamsonPfizer Inc. and Geron Corporation: Monday's Biggest LosersHere's why Pfizer and Geron were the big losers in biotech today.
Jan 27, 2014 by Dave WilliamsonOramed Pharmaceuticals: Monday’s Top StockHere's why Oramed dominated when the rest of the biotech sector fell today.
Jan 27, 2014 by Dave WilliamsonKeep an Eye on Obamacare's Strong Enrollment TrendKey trends investors need to watch.
Jan 27, 2014 by Dave WilliamsonAll Questions Answered for Ariad Pharmaceuticals Inc."Market Checkup" answers viewer questions on hot stock Ariad Pharmaceuticals.
Jan 27, 2014 by Dave WilliamsonBehind the Headlines: Key Takeawys From Intuitive Surgical, Inc.'s EarningsAfter Intuitive Surgical's earnings, the investing picture here is still far from clear.
Jan 27, 2014 by Dave Williamson1 Huge Health-Care Winner and 1 Big Pharma Loser From Last Week Friday's health-care winners and losers.
Jan 26, 2014 by Dave Williamson3 Popular Obamacare Headlines: Big Deal or All Hype?A look at several headlines surrounding Obamacare, and whether they're actually a big deal or just noise.
Jan 24, 2014 by Dave WilliamsonAsk a Fool: What is Your Foolish Take on Medical and Insurance Stocks?One Foolish analyst gives his opinion of medical and insurance stocks in today's market.
Jan 23, 2014 by Dave WilliamsonAmgen Inc’s Next Blockbuster Drug DeliversHere's what's behind the headlines with Amgen's next blockbuster drug.
Jan 23, 2014 by Dave WilliamsonThursday: 2 Big Losers in Health CareHere's why Hill-Rom Holdings and Herbalife got hammered hard today.
Jan 23, 2014 by Dave WilliamsonThursday: 1 Big Winner in Health CareAriad Pharmaceuticals delivered big for investors today. Is there still time to get in?
